source
- UniQure slated for FDA decision by May 1 as analysts see potential for first Huntington’s disease therapyUniQure said the Food and Drug Administration has set a decision date for its Huntington's disease gene therapy and is likely to hold an advisory committee meeting. The agency indicated a faster‑th…
- Legal experts advise European healthcare manufacturers on navigating complex environmental regulationsAt the RAPS Regulatory Intelligence Conference Europe in Barcelona, two legal specialists highlighted the difficulty of Europe’s environmental and sustainability rules for companies that make healt…